View Cart (0 items)


The pharmaceutical industry develops, produces and markets drugs or pharmaceuticals licensed for sale as medications. Pharmaceutical companies make pharmaceutical preparations or finished drugs; biological products, such as serums, bulk chemicals and botanicals used in making finished drugs; and diagnostic substances such as pregnancy and blood glucose kits. Pharmaceutical processing encompasses the end-process formulations have to go through, including packaging, labeling, processing and formatting drugs into tablets, liquids and gels. Bio-pharma is a collection of technologies that capitalize on the attributes of cells, such as their manufacturing capabilities, and put, biological molecules, such as DNA and proteins, to work for us.


Pfizer acquires InnoPharma

Pharmaceutical giant Pfizer Inc. has completed its acquisition of InnoPharma Inc., the company announced on Thursday.
Read More

PCI acquires clinical trail services company Biotec

Pharmaceutical packaging services provider PCI has expanded its presence in the European Union with the acquisition of Biotec Services International.
Read More

New heart failure drug could cut deaths by 20%

Swiss pharmaceuticals group Novartis is planning to launch a new drug that has the potential to cut cardiovascular death and admissions to hospital by 20%.
Read More

New facility to research personalized cellular cancer therapies

A new facility to develop personalized cellular cancer therapies will be built by the University of Pennsylvania, funded in part with a $20 million investment from Novartis.
Read More

Global pharmaceutical sales projected to reach $1 trillion in 2014

The outlook for the pharmaceutical industry is bright, according to a new report that identifies a number of positive trends.
Read More

GSK recalls batches of Eye-Mo solution

London-listed pharmaceuticals giant GlaxoSmithKline (GSK) has launched a voluntary recall of several batches of its Eye-Mo Red Eyes Formula Ophthalmic Solution.
Read More

GSK to start clinical trials on new Ebola vaccine

London-listed pharmaceuticals company GlaxoKlineSmith will start clinical safety trials for its experimental Ebola vaccine in the U.S. as early as next week.
Read More

Roche acquires InterMune for $8.3 billion in move to strengthen respiratory portfolio

Swiss pharmaceuticals group Roche revealed this week that it has agreed to acquire California-based biotechnology company InterMune Inc. in a deal worth $8.3 billion.
Read More

Tighter restrictions to be placed on hydrocodone combination products

Medicines containing hydrocodone, a highly addictive painkiller, will be subject to more restrictions under new rules published by the U.S. Drug Enforcement Administration (DEA) this week.
Read More

FDA warns consumers to avoid fraudulent Ebola treatment products

The agency said that it had seen and received consumer complaints about various products being offered online that are claimed to either prevent the Ebola virus or treat the infection.
Read More